Search Results

There are 9219 results for: content related to: Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

  1. You have free access to this content
    Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group

    Pediatric Blood & Cancer

    Volume 63, Issue 6, June 2016, Pages: 973–982, Uma H. Athale, Paul J. Gibson, Nicole M. Bradley, David M. Malkin and Johann Hitzler

    Version of Record online : 23 FEB 2016, DOI: 10.1002/pbc.25939

  2. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: A report from the Japanese Childhood Cancer and Leukemia Study Group

    Pediatric Blood & Cancer

    Volume 55, Issue 7, 15 December 2010, Pages: 1287–1295, Kazutaka Yamaji, Tomomi Okamoto, Shohei Yokota, Arata Watanabe, Yasuo Horikoshi, Keiko Asami, Atsushi Kikuta, Nobuyuki Hyakuna, Yutaka Saikawa, Junichi Ueyama, Tsutomu Watanabe, Masahiko Okada, Takashi Taga, Hirokazu Kanegane, Kazuhiro Kogawa, Motoaki Chin, Asayuki Iwai, Takeshi Matsushita, Yasuto Shimomura, Toshinori Hori, Masahito Tsurusawa and for The Japanese Childhood Cancer, Leukemia Study Group (JCCLSG)

    Version of Record online : 25 OCT 2010, DOI: 10.1002/pbc.22620

  3. You have free access to this content
    Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation

    British Journal of Haematology

    Volume 162, Issue 2, July 2013, Pages: 147–161, Dario Campana and Wing Leung

    Version of Record online : 9 MAY 2013, DOI: 10.1111/bjh.12358

  4. You have free access to this content
    Determination of minimal residual disease in leukaemia patients

    British Journal of Haematology

    Volume 121, Issue 6, June 2003, Pages: 823–838, Dario Campana

    Version of Record online : 3 JUN 2003, DOI: 10.1046/j.1365-2141.2003.04393.x

  5. You have free access to this content
    Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol

    British Journal of Haematology

    Volume 165, Issue 3, May 2014, Pages: 392–401, Virginie Gandemer, Cécile Pochon, Emmanuel Oger, Jean-Hugues H. Dalle, Gérard Michel, Claudine Schmitt, Eva de Berranger, Claire Galambrun, Hélène Cavé, Jean-Michel Cayuela, Nathalie Grardel, Elizabeth Macintyre, Geneviève Margueritte, Françoise Méchinaud, Pierre Rorhlich, Patrick Lutz, François Demeocq, Pascale Schneider, Dominique Plantaz, Marilyne Poirée and Pierre Bordigoni

    Version of Record online : 30 JAN 2014, DOI: 10.1111/bjh.12749

  6. You have free access to this content
    Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?

    British Journal of Haematology

    Volume 164, Issue 3, February 2014, Pages: 396–408, Adriana Balduzzi, Lucia Di Maio, Daniela Silvestri, Simona Songia, Sonia Bonanomi, Attilio Rovelli, Valentino Conter, Andrea Biondi, Giovanni Cazzaniga and Maria G. Valsecchi

    Version of Record online : 5 NOV 2013, DOI: 10.1111/bjh.12639

  7. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  8. You have free access to this content
    Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 133, Issue 4, May 2006, Pages: 382–388, Vincent H. J. van der Velden, Patricia G. Hoogeveen, Rob Pieters and Jacques J. M. van Dongen

    Version of Record online : 14 MAR 2006, DOI: 10.1111/j.1365-2141.2006.06056.x

  9. You have free access to this content
    Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches

    British Journal of Haematology

    Volume 144, Issue 1, January 2009, Pages: 107–115, Jacqueline Ryan, Fiona Quinn, Armelle Meunier, Ludmila Boublikova, Mireille Crampe, Prerna Tewari, Aengus O’Marcaigh, Ray Stallings, Michael Neat, Ann O’Meara, Fin Breatnach, Shaun McCann, Paul Browne, Owen Smith and Mark Lawler

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07429.x

  10. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 168, Issue 3, February 2015, Pages: 395–404, Rosemary Sutton, Peter J. Shaw, Nicola C. Venn, Tamara Law, Anuruddhika Dissanayake, Tatjana Kilo, Michelle Haber, Murray D. Norris, Chris Fraser, Frank Alvaro, Tamas Revesz, Toby N. Trahair, Luciano Dalla-Pozza, Glenn M. Marshall and Tracey A. O'Brien

    Version of Record online : 13 OCT 2014, DOI: 10.1111/bjh.13142

  11. You have free access to this content
    Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR

    British Journal of Haematology

    Volume 166, Issue 3, August 2014, Pages: 360–368, Sara Raponi, Irene Della Starza, Maria S. De Propris, Ilaria Del Giudice, Francesca R. Mauro, Marilisa Marinelli, Valeria Di Maio, Alfonso Piciocchi, Robin Foà and Anna Guarini

    Version of Record online : 16 APR 2014, DOI: 10.1111/bjh.12887

  12. Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia

    British Journal of Haematology

    Jan Zuna, Anja Moericke, Mari Arens, Rolf Koehler, Renate Panzer-Grümayer, Claus R. Bartram, Susanna Fischer, Eva Fronkova, Marketa Zaliova, André Schrauder, Martin Stanulla, Martin Zimmermann, Jan Trka, Jan Stary, Andishe Attarbaschi, Georg Mann, Martin Schrappe and Gunnar Cario

    Version of Record online : 23 FEB 2016, DOI: 10.1111/bjh.13989

  13. You have free access to this content
    The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

    Cytometry Part B: Clinical Cytometry

    Volume 76B, Issue 2, March 2009, Pages: 91–101, Adhra Al-Mawali, David Gillis and Ian Lewis

    Version of Record online : 25 AUG 2008, DOI: 10.1002/cyto.b.20444

  14. You have free access to this content
    Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

    British Journal of Haematology

    Volume 134, Issue 3, August 2006, Pages: 273–282, Nick Goulden, Paul Virgo and David Grimwade

    Version of Record online : 29 JUN 2006, DOI: 10.1111/j.1365-2141.2006.06182.x

  15. Detection of minimal residual disease in B lymphoblastic leukemia using viSNE

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 5, September/October 2015, Pages: 294–304, Joseph A. DiGiuseppe, Michelle D. Tadmor and Dana Pe'er

    Version of Record online : 2 JUN 2015, DOI: 10.1002/cyto.b.21252

  16. You have free access to this content
    Status of minimal residual disease testing in childhood haematological malignancies

    British Journal of Haematology

    Volume 143, Issue 4, November 2008, Pages: 481–489, Dario Campana

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1365-2141.2008.07350.x

  17. You have free access to this content
    Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang

    British Journal of Haematology

    Volume 158, Issue 2, July 2012, Pages: 186–197, Estelle Gimenez, Martine Chauvet, Laetitia Rabin, Isabelle Puteaud, Samuel Duley, Sieme Hamaidia, Juliana Bruder, Valérie Rolland-Neyret, Steven Le Gouill, Olivier Tournilhac, Eric Voog, Hervé Maisonneuve, Marie C. Jacob, Dominique Leroux, Marie C. Béné, Christine Formisano-Tréziny, Jean Gabert, Rémy Gressin and Mary B. Callanan

    Version of Record online : 25 MAY 2012, DOI: 10.1111/j.1365-2141.2012.09161.x

  18. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014

    Pediatric Blood & Cancer

    Volume 61, Issue S2, December 2014, Pages: S105–S433,

    Version of Record online : 16 OCT 2014, DOI: 10.1002/pbc.25314

  19. Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react

    British Journal of Haematology

    Volume 169, Issue 2, April 2015, Pages: 249–261, Cécile Pochon, Emmanuel Oger, Gérard Michel, Jean-Hugues Dalle, Alexandra Salmon, Brigitte Nelken, Yves Bertrand, Hélène Cavé, Jean-Michel Cayuela, Nathalie Grardel, Elizabeth Macintyre, Geneviève Margueritte, Françoise Méchinaud, Pierre Rohrlich, Catherine Paillard, François Demeocq, Pascale Schneider, Dominique Plantaz, Marilyne Poirée, Jean-François Eliaou, Gilbert Semana, Séverine Drunat, Philippe Jonveaux, Pierre Bordigoni and Virginie Gandemer

    Version of Record online : 19 DEC 2014, DOI: 10.1111/bjh.13272

  20. The detection and significance of minimal residual disease in acute and chronic leukemia

    Tissue Antigens

    Volume 68, Issue 5, November 2006, Pages: 371–385, N.-G. Chung, V. Buxhofer-Ausch and J. P. Radich

    Version of Record online : 7 NOV 2006, DOI: 10.1111/j.1399-0039.2006.00714.x